The Scottish biotech firm, which produces Omega-3 oils from whisky by-products, brings in new financial chief as its new industrial-scale facility is set to launch later this year.
Pharmaceutical ingredients expert Jerome Quiohilag joins the Scottish biotech startup as Associate Director, as the company prepares to scale its operations with a new production facility this year.
The biotech startup produces Omega 3 for aquaculture feed by growing algae based on whisky byproducts, described as "a very Scottish solution for a global problem".
Aiming to disrupt the aquaculture feed Omega-3 market, MiAlgae secures backing from investors including SWEN Capital Partners, Clay Capital, and Rabo Ventures.